Drive to Deprescribe: Optimizing Use of Anti-Epileptics and Anti-Seizure Medications (August 2022)
Recorded On: 08/18/2022
-
Register
- Non-member - Free!
- Member - Free!
The issue of polypharmacy and inappropriate medication use in post-acute and long-term care (PALTC) has been an ongoing concern. The PALTC setting has one of the highest polypharmacy rates, which increases the risk for adverse events and drug interactions.
Since May 2021, PALTmed and ASCP have been holding meetings and developing resources to help prescribers, pharmacists, DONs, CNOs, CMOs, and CEOs optimize medication use in the long-term care setting. This is the recording of this topic's session.
For more information and additional resources, visit paltmed.org/drive-deprescribe.
Michael Cinque, PharmD, FAPhA
Michael Cinque PharmD, FAPhA, currently serves as the Senior Vice President of Clinical Strategic Partnerships at InnovAge and operates as a consultant in Medication Use Management through Michael Cinque Consulting. Prior experience includes a role as Senior Vice President of Pharmacy Management at Genesis and as President at Enclara Pharmacia, where notable achievements included driving the integration of Enclara Pharmacia with Hospice Pharmacia. Previously, Michael Cinque held positions such as Vice President of Operations at Hospice Pharmacia, overseeing a substantial payroll and managing extensive operations, and Chief Pharmaceutical Care Officer at excelleRx Hospice Pharmacia, where responsibilities included leading clinical operations. Academic credentials consist of a Bachelor of Science in Pharmacy from Temple University School of Pharmacy and a Doctor of Pharmacy degree from the University of Florida.
Arif Nazir, MD, CMD
Arif Nazir, MD, CMD, currently serves as the Chief Medical Officer for BrightSpring Health Services, Primary Care, a large, value-based, geriatric practitioner organization, and the Chief Medical Officer for Signature HealthCARE. He is Past President for AMDA, founding member for the Society’s Innovation Council, and Co-chair of Society’s Drive to Deprescribe initiative. As a healthcare leader, researcher, entrepreneur, and an implementation champion, he continues to focus his efforts on finding practical solutions for solving care coordination gaps and on enhancing leadership and teamwork in the PALTC frontlines.
Samuel W. Terman, MD
Dr. Terman is a neurologist who specializes in caring for patients with seizures and epilepsy. He earned a BS in neuroscience from Brown University in 2009. Then, he completed his MD at the University of Michigan in 2014, and during this time also obtained an MS in Clinical Research which included training in statistics and epidemiology. He then completed his neurology residency at the University of Michigan in 2018, and pursued further subspecialty training during epilepsy fellowship at the University of Michigan.
This course is not for credit.
